D3 Bio (wuxi) Co., Ltd

This is the first human study of an experimental drug called D3L-001 for people with advanced cancers that test positive for a protein called HER2. The main goal is to find a safe dose and check for side effects in about 128 participants. Researchers will also gather early inform…

This early-stage trial is testing a new oral medication called D3S-001 for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find a safe dose, see how the body processes the drug, and get early signs of whether it helps …

This early-stage study aims to understand how eating food affects how the body absorbs and processes a new drug called D3S-001. Fourteen healthy adult volunteers will take the drug twice—once on an empty stomach and once after a high-fat meal—so researchers can compare the result…